These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35751383)

  • 1. Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis.
    Porpiglia M; Borella F; Chieppa P; Brino C; Ala A; Marra V; Castellano I; Benedetto C
    Tumori; 2023 Jun; 109(3):301-306. PubMed ID: 35751383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
    Natsiopoulos I; Intzes S; Liappis T; Zarampoukas K; Zarampoukas T; Zacharopoulou V; Papazisis K
    Clin Breast Cancer; 2019 Jun; 19(3):208-215. PubMed ID: 30922804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
    Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
    Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.
    de Boniface J; Frisell J; Kühn T; Wiklander-Bråkenhielm I; Dembrower K; Nyman P; Zouzos A; Gerber B; Reimer T; Hartmann S
    Breast Cancer Res Treat; 2022 Jun; 193(3):589-595. PubMed ID: 35451733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients.
    Goyal A; Puri S; Marshall A; Valassiadou K; Hoosein MM; Carmichael AR; Erdelyi G; Sharma N; Dunn J; York J
    Breast Cancer Res Treat; 2021 Jan; 185(2):433-440. PubMed ID: 33025481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery.
    Allweis TM; Menes T; Rotbart N; Rapson Y; Cernik H; Bokov I; Diment J; Magen A; Golan O; Levi-Bendet N; Givon Madhala O; Grubstein A
    Eur J Surg Oncol; 2020 Jun; 46(6):1041-1045. PubMed ID: 31801656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon nanoparticles localized clipped node dissection combined with sentinel lymph node biopsy with indocyanine green and methylene blue after neoadjuvant therapy in node positive breast cancer in China: initial results of a prospective study.
    Yang X; Li Y; Ren XT; Fan L; Hua B
    World J Surg Oncol; 2023 Jul; 21(1):214. PubMed ID: 37480099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Park S; Koo JS; Kim GM; Sohn J; Kim SI; Cho YU; Park BW; Park VY; Yoon JH; Moon HJ; Kim MJ; Kim EK
    Cancer Res Treat; 2018 Jul; 50(3):801-812. PubMed ID: 28814071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer.
    Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR
    Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
    Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
    Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes.
    Aragon-Sanchez S; Oliver-Perez MR; Madariaga A; Tabuenca MJ; Martinez M; Galindo A; Arroyo ML; Gallego M; Blanco M; Ciruelos-Gil EM
    Breast J; 2022; 2022():1507881. PubMed ID: 36051467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results.
    Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
    Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta-analysis.
    Song YX; Xu Z; Liang MX; Liu Z; Hou JC; Chen X; Xu D; Fei YJ; Tang JH
    Cancer Med; 2022 Nov; 11(22):4085-4103. PubMed ID: 35502768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.
    Takei H; Yoshida T; Kurosumi M; Inoue K; Matsumoto H; Hayashi Y; Higuchi T; Uchida S; Ninomiya J; Kubo K; Oba H; Nagai S; Tabei T
    Int J Clin Oncol; 2013 Jun; 18(3):547-53. PubMed ID: 22588780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment.
    Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
    Surg Oncol; 2021 Sep; 38():101629. PubMed ID: 34171793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer - Evaluation of Feasibility and Review of Current Recommendations.
    Malter W; Eichler C; Hanstein B; Mallmann P; Holtschmidt J
    In Vivo; 2020; 34(3):1207-1213. PubMed ID: 32354911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node.
    Patel R; MacKerricher W; Tsai J; Choy N; Lipson J; Ikeda D; Pal S; De Martini W; Allison KH; Wapnir IL
    Ann Surg Oncol; 2019 Aug; 26(8):2452-2458. PubMed ID: 31087176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?
    Costarelli L; Arienzo F; Broglia L; La Pinta M; Scavina P; Meli EZ; Colavito MH; Ascarelli A; Campagna D; Mastropietro T; Manna E; Amato M; Andrulli AD; Schiavone A; Minelli M; Fortunato L
    Ann Surg Oncol; 2024 May; 31(5):3186-3193. PubMed ID: 38427160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
    Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
    Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients.
    Pinto CS; Peleteiro B; Pinto CA; Osório F; Costa S; Magalhães A; Mora H; Amaral J; Gonçalves D; Fougo JL
    Breast Cancer; 2022 Jul; 29(4):709-719. PubMed ID: 35304711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.